Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

NCT: NCT06149650 · RECRUITING

NCT IDNCT06149650
StatusRECRUITING
Start Date2024-07-15
Completion2028-12-31

Brief Summary

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.

Frequently Asked Questions

What is Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study?

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study is a clinical trial registered under NCT06149650. Current status: RECRUITING.

What is the status of NCT06149650?

The current status of NCT06149650 (Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study) is: RECRUITING.

When did Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study start?

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study started on 2024-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑